Evidence map›Paper›PMID 22279613›Full record

ArticleCellular logistics

ArfGAP1 promotes COPI vesicle formation by facilitating coatomer polymerization.

Yoko Shiba, Ruibai Luo, Jenny E Hinshaw, Tomasz Szul, Ryo Hayashi, Elizabeth Sztul, Kunio Nagashima, Ulrich Baxa, Paul A Randazzo

Open access · hybridAbstract read
In one paragraph

Article in Cellular logistics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Arfs on the Golgi: four conductors, one orchestra.Frontiers in molecular biosciences · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. ArfGAPs: key regulators for receptor sorting.Receptors & clinical investigation · 2014
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Yoko Shiba *Laboratory of Cellular and Molecular Biology; National Cancer Institute, Bethesda, MD USA.
Ruibai Luo *Laboratory of Cellular and Molecular Biology; National Cancer Institute, Bethesda, MD USA.
Jenny E HinshawNational Institute of Diabetes and Digestive and Kidney Disease; National Institutes of Health; Bethesda, MD USA.
Tomasz SzulDepartment of Cell Biology; The University of Alabama at Birmingham; Birmingham, AL USA.
Ryo HayashiLaboratory of Cell Biology; National Cancer Institute; Bethesda, MD USA.
Elizabeth SztulDepartment of Cell Biology; The University of Alabama at Birmingham; Birmingham, AL USA.
Kunio NagashimaElectron Microscopy Laboratory, ATP, SAIC-Frederick, Center for Cancer Research, National Cancer Institute; Frederick, MD USA.
Ulrich BaxaElectron Microscopy Laboratory, ATP, SAIC-Frederick, Center for Cancer Research, National Cancer Institute; Frederick, MD USA.
Paul A RandazzoLaboratory of Cellular and Molecular Biology; National Cancer Institute, Bethesda, MD USA.
National Cancer Institute · USCenter for Cancer Research · USNational Institutes of Health · USScience Applications International Corporation (United States) · USSt. Vincent's Birmingham · USUniversity of Alabama at Birmingham · US

Funding

Regulation of ADP-ribosylation factorZIABC007365 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RANDAZZO, PAUL A · 2009 to 2025
$27.9M
Structure And Function Of Dynamin, A 100kd GTPase Involved In EndocytosisZIADK060100 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HINSHAW, JENNY E · 2009 to 2025
$10.8M
6 · The paper itself

Abstract

The role of ArfGAP1 in COPI vesicle biogenesis has been controversial. In work using isolated Golgi membranes, ArfGAP1 was found to promote COPI vesicle formation. In contrast, in studies using large unilamellar vesicles (LUVs) as model membranes, ArfGAP1 functioned as an uncoating factor inhibiting COPI vesicle formation. We set out to discriminate between these models. First, we reexamined the effect of ArfGAP1 on LUVs. We found that ArfGAP1 increased the efficiency of coatomer-induced deformation of LUVs. Second, ArfGAP1 and peptides from cargo facilitated self-assembly of coatomer into spherical structures in the absence of membranes, reminiscent of clathrin self-assembly. Third, in vivo, ArfGAP1 overexpression induced the accumulation of vesicles and allowed normal trafficking of a COPI cargo. Taken together, these data support the model in which ArfGAP1 promotes COPI vesicle formation and membrane traffic and identify a function for ArfGAP1 in the assembly of coatomer into COPI.

Indexed as

ADP-ribosylation factorArfGTPase-activating proteincoatomerGolgi apparatusmembrane traffic

Identifiers

PMID22279613
PMCPMC3265926
OpenAlexW1970954184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.